<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01728597</url>
  </required_header>
  <id_info>
    <org_study_id>CMR-12-TECH-02</org_study_id>
    <nct_id>NCT01728597</nct_id>
  </id_info>
  <brief_title>Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols</brief_title>
  <acronym>CMR-TECH</acronym>
  <official_title>Optimization of Non-contrast Enhanced 1.5 Tesla and 3 Tesla Cardiac Magnetic Resonance Imaging Techniques and Acquisition of Normal Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amt der Steiermärkischen Landesregierung, Abteilung 3</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the main problems in cardiac magnetic resonance (MR) investigations is the strong&#xD;
      dependence of the achieved image quality on optimal settings of sequence parameters and&#xD;
      anatomical and physiological situations and it is well known that the diagnostic impact of&#xD;
      cardiac MR investigations crucially depends on the adaption of imaging protocols to patients'&#xD;
      state and ability to cooperate.&#xD;
&#xD;
      The aim of the present study is the evaluation and optimization of various 1.5 Tesla and 3&#xD;
      Tesla cardiac MR investigation protocols without application of contrast agent as well as the&#xD;
      acquisition of normal values for new cardiac MR images techniques:&#xD;
&#xD;
        -  normal myocardial morphology: T1-, T2- and T2*-weighted imaging and acquisition of&#xD;
           normal values of magnetic relaxation times (sequence- and protocol dependent),&#xD;
&#xD;
        -  normal cardiac function: systolic and diastolic function (sequence- and protocol&#xD;
           dependent),&#xD;
&#xD;
        -  coronary artery imaging: feasibility to evaluate length, diameter and blood flow&#xD;
           (sequence- and protocol dependent),&#xD;
&#xD;
        -  normal blood flow topologies in the heart and the surrounding great vessels: 2D- and 3D&#xD;
           blood flow imaging and evaluation techniques (sequence- and protocol dependent).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac volumes</measure>
    <time_frame>up to 1 week</time_frame>
    <description>volumes of cardiac chambers in the cardiac cycle [ml], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac performance</measure>
    <time_frame>up to 1 week</time_frame>
    <description>ejection fraction of cardiac chambers [%], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac muscle mass</measure>
    <time_frame>up to 1 week</time_frame>
    <description>systolic and end-diastolic mass of cardiac chambers [g], sequence- and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coronary artery anatomy</measure>
    <time_frame>up to 1 week</time_frame>
    <description>length and diameter [mm], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow velocity</measure>
    <time_frame>up to 1 week</time_frame>
    <description>maximum, minimum and average velocity [cm/s], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow vorticity</measure>
    <time_frame>up to 1 week</time_frame>
    <description>number of vortices of blood flow in the heart and surrounding great vessels, sequence and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood flow timing</measure>
    <time_frame>up to 1 week</time_frame>
    <description>time points of characteristic blood flow patterns in the heart and surrounding great vessels in the cardiac cycle [ms], sequence-, and protocol dependent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>magnetic relaxation times</measure>
    <time_frame>up to 1 week</time_frame>
    <description>systolic and diastolic T1, T2, T2* [ms], sequence- and protocol dependent</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <description>MR compliant volunteers with no history of cardiovascular diseases</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No history of cardiac or pulmonary diseases&#xD;
&#xD;
          -  ability to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  General MR exclusion criteria eg. patients with metal devices or other magnetic&#xD;
             material in or on the subjects body which will be hazardous for MR investigation (e.g.&#xD;
             heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants,&#xD;
             coloured contact lenses, patch to deliver medications through the skin, any metal&#xD;
             implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or&#xD;
             any metal fragments or shrapnel in the body),&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  claustrophobia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Reiter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ursula Reiter, PhD</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>83347</phone_ext>
    <email>ursula.reiter@klinikum-graz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
    <phone>+43-316-385</phone>
    <phone_ext>2411</phone_ext>
    <email>michael.fuchsjaeger@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Unitersity Graz, Department of Radiology, Division of General Radiology</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>2411</phone_ext>
      <email>michael.fuchsjaeger@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Ursula Reiter, PhD</last_name>
      <phone>+43-316-385</phone>
      <phone_ext>83347</phone_ext>
      <email>ursula.reiter@klinikum-graz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Ursula Reiter, PD DI Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gert Reiter, PD DI Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clemens Reiter, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corina Kräuter, DI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Fuchsjäger, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Kräuter C, Reiter U, Reiter C, Nizhnikava V, Masana M, Schmidt A, Fuchsjäger M, Stollberger R, Reiter G. Automated mitral valve vortex ring extraction from 4D-flow MRI. Magn Reson Med. 2020 Dec;84(6):3396-3408. doi: 10.1002/mrm.28361. Epub 2020 Jun 18.</citation>
    <PMID>32557819</PMID>
  </reference>
  <results_reference>
    <citation>Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization. Radiology. 2014 May;271(2):365-72. doi: 10.1148/radiol.13131225. Epub 2013 Dec 6.</citation>
    <PMID>24475837</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 3, 2012</study_first_submitted>
  <study_first_submitted_qc>November 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2012</study_first_posted>
  <last_update_submitted>December 14, 2020</last_update_submitted>
  <last_update_submitted_qc>December 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Ursula Reiter</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>no history of cardiovascular diseases</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

